Skip to main content

Published locations for Low-dose erlotinib seems feasible for frail, elderly patients with NSCLC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Low-dose erlotinib seems feasible for frail, elderly patients with NSCLC

User login

  • Reset your password
  • /content/low-dose-erlotinib-seems-feasible-frail-elderly-patients-nsclc
  • /fedprac/article/222675/lung-cancer/low-dose-erlotinib-seems-feasible-frail-elderly-patients-nsclc
  • /oncologypractice/article/222675/lung-cancer/low-dose-erlotinib-seems-feasible-frail-elderly-patients
  • /fedprac/avaho/article/222675/lung-cancer/low-dose-erlotinib-seems-feasible-frail-elderly-patients
  • /hematology-oncology/article/222675/lung-cancer/low-dose-erlotinib-seems-feasible-frail-elderly
  • /chestphysician/article/222675/lung-cancer/low-dose-erlotinib-seems-feasible-frail-elderly-patients